Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ptongyoo
    Junior Member
    • Mar 2009
    • 7

    #1

    The coverage of re-sequencing sample

    Hi guys, I'm learning and planning to do the human genome re-sequencing project for identifying some structural variants.

    I got many samples and base on my researched one sample is require one entire flow cell for 3X coverage. So, my question is how many coverage time is require for doing this, just 3 times coverage is enough for both entire genome re-sequencing and RNA-seq sequencing ?
    Bioinformatics Intern.
    Master program in Bioinformatics.
  • Melissa
    Senior Member
    • Aug 2008
    • 124

    #2
    I'm not sure if I understand you correctly. Are you doing re-sequencing for the whole human genome? Since you have many samples, I guess you're considering targeted re-sequencing? But since you said one flow cell is estimated to give 3x coverage (3.2Gb x 3 = ~10Gb)... it sounds like you're sequencing the whole genome.

    The easy way (but not the correct way) to estimate coverage is c = expected total amount of data/size of target. There's really no way to tell if you sequence an entire flow cell, you will get at least 3 reads at the each place. Therefore, I think 3x coverage is not sufficient. Anyway, I don't know what's the standard for re-sequencing so please don't listen to me!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 02:55 AM
    0 responses
    4 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Working...